Identification and evaluation of helvolic acid as an antibacterial compound against Neisseria gonorrhoeae
Bioscience, Biotechnology, and Biochemistry · 20.05.2026 · 90 (6) · 780-784
DOI: 10.1093/bbb/zbag043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, online erschienen am 25.03.2026. Verfasst von Sota Honma und 12 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Infection Control Sciences, Kitasato University, Minato-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Anti-Bacterial Agents, Fusidic Acid. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Platform Project for Supporting Drug Discovery, Life Science Research, Basis for Supporting Innovative Drug Discovery and Life Science Research.
Abstract (Originalsprache)
Neisseria gonorrhoeae infection causes significant morbidity and can have serious long-term impacts on reproductive and neonatal health. Global rates of N. gonorrhoeae infection have been increasing steadily over the past 20 years, and rates of resistance to key antibiotics have also continued to increase. Given the situation, the United States Centers for Disease Control and Prevention (CDC) identified drug-resistant N. gonorrhoeae as an urgent threat to public health. In this study, we aimed to discover antibacterial compounds against N. gonorrhoeae from an in-house fungal culture broth library. After the screening program, we identified helvolic acid (1), produced by Aspergillus unilateralis FKI-6908 strain, as a target antibacterial compound. Compound 1 demonstrated great antibacterial activity even against drug-resistant N. gonorrhoeae clinical isolate strains, suggesting its potential for the treatment of N. gonorrhoeae infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Infection Control Sciences, Kitasato University, Minato-ku, Tokyo, Japan.
- Ōmura Satoshi Memorial Institute, Kitasato University, Minato-ku, Tokyo, Japan.
- Department of Internal Medicine, Mount Carmel Health System, Grove City, OH, USA.
ORCID-Profile: Yukihiro Asami
Förderung
- Platform Project for Supporting Drug Discovery
- Life Science Research
- Basis for Supporting Innovative Drug Discovery and Life Science Research
- AMED
- Japan Society for the Promotion of Science
Zitieren
APA
Honma, S., Kimishima, A., Matsui, H., Nishitomi, A., Negami, S., Kamo, T., Ujie, Y., Wasuwanich, P., Honsho, M., Kojima, H., Tokiwa, T., Sugawara, A., & Asami, Y. (2026). Identification and evaluation of helvolic acid as an antibacterial compound against Neisseria gonorrhoeae. Bioscience, Biotechnology, and Biochemistry, 90(6), 780-784. https://doi.org/10.1093/bbb/zbag043
Vancouver
Honma S, Kimishima A, Matsui H, Nishitomi A, Negami S, Kamo T, et al. Identification and evaluation of helvolic acid as an antibacterial compound against Neisseria gonorrhoeae. Bioscience, Biotechnology, and Biochemistry. 2026;90(6):780-784. doi:10.1093/bbb/zbag043
BibTeX
@article{Honma2026,
author = {Honma, Sota and Kimishima, Aoi and Matsui, Hidehito and Nishitomi, Atsuka and Negami, Sota and Kamo, Taichi and Ujie, Yukiko and Wasuwanich, Paul and Honsho, Masako and Kojima, Hiroki and Tokiwa, Toshiyuki and Sugawara, Akihiro and Asami, Yukihiro},
title = {Identification and evaluation of helvolic acid as an antibacterial compound against Neisseria gonorrhoeae},
journal = {Bioscience, Biotechnology, and Biochemistry},
year = {2026},
volume = {90},
number = {6},
pages = {780--784},
doi = {10.1093/bbb/zbag043}
}
EUVIMED